Article

Predicting Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical Data

2024-08-08

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objective</h4> To develop and externally validate models to predict probabilities of alpha-synuclein (a-syn) positive or negative status in vivo in a mixture of people with and without Parkinson’s disease (PD) using easily accessible clinical predictors. <h4>Methods</h4> Uni- and multi-variable logistic regression models were developed in a cohort of participants from the Parkinson Progres...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b64679a6-1dc9-5ffd-9846-5149cba4d653
DOI: 10.1101/2024.08.07.24311578

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predicting Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical DataDOI 10.1101/2024.08.07.24311578Read

Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson’s disease in the PPMI cohortSemantic proximity Read

Diagnostic and prognostic value of alpha-synuclein seed amplification assay in Parkinson’s disease: a longitudinal cohort studySemantic proximity Read

Assessment of heterogeneity and disease onset in the Parkinson’s Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional studySemantic proximity Read

Faster reaction times of CSF Alpha-Synuclein Seed Amplification Assay predict the Diffuse Malignant subtype of Parkinson’s Disease at 10-year follow-upSemantic proximity Read

Quantitative Measurements of α-Synuclein Seeds in CSF Inform Diagnosis of SynucleinopathiesSemantic proximity Read

LRRK2-Associated Parkinsonism With and Without<i>In Vivo</i>Evidence of Alpha-Synuclein AggregatesSemantic proximity Read

The α-Synuclein Seeding Amplification Assay for Parkinson’s DiseaseSemantic proximity Read

Digital risk score sensitively identifies presence of α-synuclein aggregation or dopaminergic deficitSemantic proximity Read

Parkinson’s Disease: From Gene–Environment Risk to Precision TherapySemantic proximity Read

Synuclein and dopamine transporter biomarkers among phenoconverters to parkinsonian disordersSemantic proximity Read

The α-Synuclein seeding assay discriminates between LRRK2 p.Gly2019Ser variant carriers with and without Parkinson’s diseaseSemantic proximity Read

LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterizationSemantic proximity Read